CRBP Corbus Pharmaceuticals

• $126K bought by 1 insider
• $344K sold by 1 insider outside a trading plan
• $1.1M sold by 6 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Yong Ben Director
   Planned sale
   $16K 2,000 shares at $7.84 18% of stake
   Traded Sep 14 Filed Sep 15
   ↗
3. Nishant C Saxena Chief Business Officer
   Buy
   $25K 2,600 shares at $9.63 +3.5% to stake
   Traded Aug 11 Filed Aug 12
   ↗
4. Yuval Cohen CEO
   Planned sale
   $171K 17,000 shares at $10.08 9.8% of stake
   Traded Aug 7 Filed Aug 10
   ↗
5. Sean F. Moran CFO
   Planned sale
   $121K 12,000 shares at $10.08 12% of stake
   Traded Aug 7 Filed Aug 10
   ↗
6. Winston Kung Director
   Planned sale
   $16K 2,026 shares at $7.91 14% of stake
   Traded Jun 10 Filed Jun 11
   ↗
7. John Kenneth Jenkins Director
   Planned sale
   $38K 4,800 shares at $7.91 56% of stake
   Traded Jun 10 Filed Jun 11
   ↗
8. Anne Altmeyer Director
   Planned sale
   $19K 2,412 shares at $7.91 24% of stake
   Traded Jun 10 Filed Jun 11
   ↗
9. Nishant C Saxena Chief Business Officer
   Buy
   $101K 13,500 shares at $7.50 +22% to stake
   Traded Jun 2–3 Filed Jun 3
   ↗
10. Cormorant Asset Management, LP 10% owner, +2 joint filers
    Sale
    $344K 30,029 shares at $11.46 1.3% of stake
    Traded Dec 11, 2025 Filed Dec 15, 2025
    ↗
11. Yuval Cohen CEO
    Planned sale
    $471K 27,633 shares at $17.05 17% of stake
    Traded Oct 24–27 Filed Oct 27, 2025
    ↗
12. Sean F. Moran CFO
    Planned sale
    $221K 12,981 shares at $17.02 15% of stake
    Traded Oct 24, 2025 Filed Oct 27, 2025
    ↗
13. Anne Altmeyer Director
    Planned sale
    $22K 1,060 shares at $20.50 15% of stake
    Traded Oct 20, 2025 Filed Oct 21, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 12 stock grants, 6 sales to cover taxes, and 3 option exercises.